Otonomy Reports First Quarter 2020 Financial Results and Provides Corporate Update

Back to Jobs

Conference call to review status of clinical trials and timing to results to be held in June SAN DIEGO , May 07, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported financial

Apply Now